T3 Trial: Triage, Treatment and Transfer of Patients with Stroke in Emergency Departments
- Conditions
- Stroke - HaemorrhagicStrokeHealth services researchStroke - Ischaemic
- Registration Number
- ACTRN12614000939695
- Lead Sponsor
- Prof Sandy Middleton
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1294
Cluster level (ED): Hospitals with EDs located in the Australian states of New South Wales, Queensland, Victoria and Australian Capital Territory
Patient level: English-speaking; admitted to the stroke unit via ED with a clinical diagnosis of ischaemic stroke or intracerebral haemorrhage; presented to hospital less than 48 hours from symptom onset; access to a telephone.
Presenting to hospital more than 48 hours from symptom onset; requiring palliative care only; identified non-cerebrovascular causes of acute focal neurological deficits (seizure, hypoglycaemia, toxic or metabolic encephalopathies); sub-arachnoid haemorrhage; and acute and chronic subdural haemorrhage.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death or dependency (defined as modified Rankin Scale [mRS] >= 2)<br><br><br>[Timepoint: 90-days post-hospital admission]
- Secondary Outcome Measures
Name Time Method Secondary Outcome 1:<br>Barthel Index [BI]) >= 95 (dependency score)<br><br>[Timepoint: 90 days post hospital admission];Secondary Outcome 2:<br>mean SF-36 Physical Component Score [PCS]<br><br>[Timepoint: 90 days post hospital admission];Secondary Outcome 3:<br>mean SF-36 Mental Component Score [MCS] <br><br>[Timepoint: 90-days post-hospital admission]